These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36181033)

  • 81. Identification and validation of the necroptosis-related gene signature related to prognosis and tumor immune in hepatocellular carcinoma.
    Xiang Z; Mranda GM; Zhou X; Xue Y; Wang Y; Wei T; Liu J; Ding Y
    Medicine (Baltimore); 2022 Sep; 101(36):e30219. PubMed ID: 36086716
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
    Su Y; Zhang T; Tang J; Zhang L; Fan S; Zhou J; Liang C
    Front Oncol; 2021; 11():640150. PubMed ID: 33869028
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma.
    Song J; Peng J; Zhu C; Bai G; Liu Y; Zhu J; Liu J
    Cell Physiol Biochem; 2018; 48(6):2549-2562. PubMed ID: 30121668
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A panel of eight autophagy-related long non-coding RNAs is a good predictive parameter for clear cell renal cell carcinoma.
    Gui CP; Cao JZ; Tan L; Huang Y; Tang YM; Li PJ; Chen YH; Lu J; Yao HH; Chen ZH; Pan YH; Ye YL; Qin ZK; Chen W; Wei JH; Luo JH
    Genomics; 2021 Mar; 113(2):740-754. PubMed ID: 33516849
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma.
    Xu S; Liu D; Chang T; Wen X; Ma S; Sun G; Wang L; Chen S; Xu Y; Zhang H
    Front Genet; 2022; 13():938259. PubMed ID: 35910212
    [No Abstract]   [Full Text] [Related]  

  • 86. Identification of a competing endogenous RNA network related to immune signature in clear cell renal cell carcinoma.
    Zhang Y; Dai J; Huang W; Chen Q; Chen W; He Q; Chen F; Zhang P
    Aging (Albany NY); 2021 Dec; 13(24):25980-26002. PubMed ID: 34958632
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Establishing a Prognostic Model Based on Three Genomic Instability-related LncRNAs for Clear Cell Renal Cell Cancer.
    Lulu S; Hualing H; Shan Z; Dianxi C; Yiqing L; Qin L
    Clin Genitourin Cancer; 2022 Aug; 20(4):e317-e329. PubMed ID: 35321833
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A novel necroptosis-related lncRNA signature for predicting prognosis and immune response of colon cancer.
    Luo J; Peng J; Xiao W; Huang S; Cao Y; Wang T; Wang X
    Front Genet; 2022; 13():984696. PubMed ID: 36092933
    [No Abstract]   [Full Text] [Related]  

  • 89. Molecular subtypes of clear cell renal carcinoma based on PCD-related long non-coding RNAs expression: insights into the underlying mechanisms and therapeutic strategies.
    Wang H; Liu Y; Tang A; Zhang X
    Eur J Med Res; 2024 May; 29(1):292. PubMed ID: 38773560
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Construction and Validation of a Novel Cuproptosis-Related Seven-lncRNA Signature to Predict the Outcomes, Immunotherapeutic Responses, and Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma.
    Zhang H; Ning Z; Wang B; Liu Y; Tao B; Zhang G; Liu H; Wang C
    Dis Markers; 2023; 2023():7219794. PubMed ID: 36741910
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Cross-talk between necroptosis-related lncRNAs to construct a novel signature and predict the immune landscape of lung adenocarcinoma patients.
    Wu J; Song D; Zhao G; Chen S; Ren H; Zhang B
    Front Genet; 2022; 13():966896. PubMed ID: 36186456
    [No Abstract]   [Full Text] [Related]  

  • 92. Integrating bulk and single-cell RNA sequencing data to establish necroptosis-related lncRNA risk model and analyze the immune microenvironment in hepatocellular carcinoma.
    Zhang R; Li Q; Yu X; Hou Y; Yan L; Gao Y; Ji L; Zhang X; Fang M; Huang L; Yu Z; Gao Y; Li M
    Heliyon; 2023 Nov; 9(11):e22083. PubMed ID: 38034714
    [TBL] [Abstract][Full Text] [Related]  

  • 93. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
    Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X
    Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A Notch signaling-related lncRNA signature for predicting prognosis and therapeutic response in clear cell renal cell carcinoma.
    Zhang L; Li Y; Cai B; Chen J; Zhao K; Li M; Lang J; Wang K; Pan S; Zhu K
    Sci Rep; 2023 Nov; 13(1):21141. PubMed ID: 38036719
    [TBL] [Abstract][Full Text] [Related]  

  • 95. A new CCCH-type zinc finger-related lncRNA signature predicts the prognosis of clear cell renal cell carcinoma patients.
    Shen C; Chen Z; Jiang J; Zhang Y; Xu W; Peng R; Zuo W; Jiang Q; Fan Y; Fang X; Zheng B
    Front Genet; 2022; 13():1034567. PubMed ID: 36246657
    [No Abstract]   [Full Text] [Related]  

  • 96. The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma.
    Cheng Y; Yang S; Shen Y; Ding B; Wu W; Zhang Y; Liang G
    DNA Cell Biol; 2020 Apr; 39(4):645-653. PubMed ID: 32045269
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Identification of a novel m6A-related lncRNA pair signature for predicting the prognosis of gastric cancer patients.
    Wang JM; Li X; Yang P; Geng WB; Wang XY
    BMC Gastroenterol; 2022 Feb; 22(1):76. PubMed ID: 35189810
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A novel autophagy-related long non-coding RNAs prognostic risk score for clear cell renal cell carcinoma.
    Tang F; Tang Z; Lu Z; Cai Y; Lai Y; Mai Y; Li Z; Lu Z; Zhang J; Li Z; He Z
    BMC Urol; 2022 Dec; 22(1):203. PubMed ID: 36496360
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Analysis of lncRNAs profiles associated with ferroptosis can predict prognosis and immune landscape and drug sensitivity in patients with clear cell renal cell carcinoma.
    Zong H; Li A; Huang Y; Che X; Zhang Y; Ma G; Zhou Z
    J Biochem Mol Toxicol; 2023 Nov; 37(11):e23464. PubMed ID: 37477388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.